The MRNA-LNP Vaccines - the Good, the Bad and the Ugly?

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Feb 23

PMID 38390323

Authors

Botond Z Igyarto

Zhen Qin

Affiliations

Soon will be listed here.

Abstract

The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries. Based on early clinical trial data, these vaccines were deemed safe and effective for all demographics. However, the latest data raise serious concerns about the safety and effectiveness of these vaccines. Here, we review some of the safety and efficacy concerns identified to date. We also discuss the potential mechanism of observed adverse events related to the use of these vaccines and whether they can be mitigated by alterations of this vaccine mechanism approach.

Citing Articles

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.

Imani S, Li X, Chen K, Maghsoudloo M, Jabbarzadeh Kaboli P, Hashemi M Front Cell Infect Microbiol. 2025; 14:1501010.

PMID: 39902185 PMC: 11788159. DOI: 10.3389/fcimb.2024.1501010.

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines.

Chentoufi A, Ulmer J, BenMohamed L Vaccines (Basel). 2025; 13(1).

PMID: 39852809 PMC: 11769099. DOI: 10.3390/vaccines13010030.

Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.

Fekete M, Lehoczki A, Szappanos A, Toth A, Mahdi M, Sotonyi P Geroscience. 2025; 47(1):745-779.

PMID: 39777702 PMC: 11872997. DOI: 10.1007/s11357-024-01487-4.

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery.

Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C Vaccines (Basel). 2024; 12(10).

PMID: 39460315 PMC: 11510967. DOI: 10.3390/vaccines12101148.

Synergistic integration of mRNA-LNP with CAR-engineered immune cells: Pioneering progress in immunotherapy.

Chen Z, Shu J, Hu Y, Mei H Mol Ther. 2024; 32(11):3772-3792.

PMID: 39295145 PMC: 11573621. DOI: 10.1016/j.ymthe.2024.09.019.

References

Satomi H, Katano H, Kanno H, Kobayashi M, Ohkuma Y, Hashidume N . An autopsy case of fulminant myocarditis after severe acute respiratory syndrome coronavirus 2 vaccine inoculation. Pathol Int. 2022; 72(10):519-524. PMC: 9537995. DOI: 10.1111/pin.13267. View

Zhang L, Richards A, Barrasa M, Hughes S, Young R, Jaenisch R . Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A. 2021; 118(21). PMC: 8166107. DOI: 10.1073/pnas.2105968118. View

Kariko K, Buckstein M, Ni H, Weissman D . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005; 23(2):165-75. DOI: 10.1016/j.immuni.2005.06.008. View

Seneff S, Nigh G, Kyriakopoulos A, McCullough P . Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol. 2022; 164:113008. PMC: 9012513. DOI: 10.1016/j.fct.2022.113008. View

Ludvigsson J, Engerstrom L, Nordenhall C, Larsson E . Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. N Engl J Med. 2021; 384(7):669-671. PMC: 7821981. DOI: 10.1056/NEJMc2026670. View

Morz M . A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19. Vaccines (Basel). 2022; 10(10). PMC: 9611676. DOI: 10.3390/vaccines10101651. View

Fong W, Woon T, Chew L, Low A, Law A, Poh Y . Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study. Adv Rheumatol. 2023; 63(1):38. DOI: 10.1186/s42358-023-00316-0. View

Pira A, Moltrasio C, Abeni D, Corra A, Marzano A, Caproni M . Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study. Front Med (Lausanne). 2023; 10:1160672. PMC: 10060545. DOI: 10.3389/fmed.2023.1160672. View

Kariko K, Muramatsu H, Welsh F, Ludwig J, Kato H, Akira S . Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther. 2008; 16(11):1833-40. PMC: 2775451. DOI: 10.1038/mt.2008.200. View

10.

Uversky V, Redwan E, Makis W, Rubio-Casillas A . IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein. Vaccines (Basel). 2023; 11(5). PMC: 10222767. DOI: 10.3390/vaccines11050991. View

11.

Tahtinen S, Tong A, Himmels P, Oh J, Paler-Martinez A, Kim L . IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 2022; 23(4):532-542. DOI: 10.1038/s41590-022-01160-y. View

12.

Miller I, Metcalf C . Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2. R Soc Open Sci. 2022; 9(1):211021. PMC: 8728167. DOI: 10.1098/rsos.211021. View

13.

Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan R . Letter to the editor. Vaccine. 2023; 48:125067. PMC: 10272990. DOI: 10.1016/j.vaccine.2023.06.035. View

14.

Chow B, Lai C . Lymphohistiocytic Myocarditis Possibly Due to Moderna mRNA-1273 Vaccine. Am J Clin Pathol. 2022; 158(2):167-172. DOI: 10.1093/ajcp/aqac029. View

15.

Szebeni J, Storm G, Ljubimova J, Castells M, Phillips E, Turjeman K . Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nat Nanotechnol. 2022; 17(4):337-346. DOI: 10.1038/s41565-022-01071-x. View

16.

Shrestha N, Burke P, Nowacki A, Simon J, Hagen A, Gordon S . Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine. Open Forum Infect Dis. 2023; 10(6):ofad209. PMC: 10234376. DOI: 10.1093/ofid/ofad209. View

17.

Devaux C, Camoin-Jau L . Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection. Viruses. 2023; 15(5). PMC: 10222462. DOI: 10.3390/v15051045. View

18.

Igyarto B, Jacobsen S, Ndeupen S . Future considerations for the mRNA-lipid nanoparticle vaccine platform. Curr Opin Virol. 2021; 48:65-72. PMC: 8065267. DOI: 10.1016/j.coviro.2021.03.008. View

19.

Parry P, Lefringhausen A, Turni C, Neil C, Cosford R, Hudson N . 'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA. Biomedicines. 2023; 11(8). PMC: 10452662. DOI: 10.3390/biomedicines11082287. View

20.

Edelman A, Boniface E, Male V, Cameron S, Benhar E, Han L . Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data. BMJ Med. 2022; 1(1). PMC: 9665108. DOI: 10.1136/bmjmed-2022-000297. View